|
Demographic characteristics
|
|
Age (in years)
|
41.20 ± 11.34
|
|
Gender
|
|
Female
|
66 (62.86%)
|
|
Male
|
39 (37.14%)
|
|
Race
|
|
Caucasian
|
57 (54.29%)
|
|
Hispanic
|
35 (33.33%)
|
|
African-American
|
13 (12.38%)
|
|
Clinical characteristics
|
|
Mood state
|
|
YMRS
|
14.62 ± 9.27
|
|
IDS-30-C
|
24.52 ± 12.18
|
|
Psychiatric medication status
|
|
Medicated
|
90 (86.54%)
|
|
Unmedicated
|
14 (13.64%)
|
|
Lithium
|
19 (18.10%)
|
|
Anticonvulsants
|
56 (53.33%)
|
|
Antidepressants
|
45 (42.86%)
|
|
Antipsychotics
|
55 (52.38%)
|
|
Benzodiazepines
|
26 (24.76%)
|
|
Actigraphic assessments
|
|
Interdaily stability (IS)
|
0.52 ± 0.15
|
|
Intradaily variability (IV)
|
0.67 ± 0.20
|
|
Relative amplitude (RA)
|
0.80 ± 0.14
|
|
Goodness-of-fit (GOF)
|
0.46 ± 0.13
|
|
Sleep efficiency
|
66.02 ± 13.55
|
|
Sleep percent
|
31.42 ± 7.08
|
|
Average daily sleep time (in hours)
|
7.49 ± 2.19
|
|
24-h correlation
|
0.25 ± 0.13
|
|
Mesor
|
2925.24 ± 1604.64
|
|
Amplitude
|
2159.33 ± 1235.05
|
|
Circadian quotient (CQ)
|
0.74 ± 0.17
|
|
Activity mean
|
2843.84 ± 1565.51
|
|
Activity median
|
1852.60 ± 1614.06
|
|
Acceleration index
|
38.26 ± 115.35
|
|
Activity index
|
65.48 ± 29.87
|
|
Clinical chronobiological assessments
|
|
5-Item Social Rhythm Metric (SRM-5)
|
3.79 ± 1.30
|
|
Pittsburgh Sleep Quality Index (PSQI)
|
10.30 ± 4.04
|
